In vitro culture is a direct detection method for the presence of living bacteria. This protocol describes methods for the culture of diverse Borrelia spirochetes, including those of the Borrelia burgdorferi sensu lato complex, relapsing fever Borrelia species, and Borrelia miyamotoi. These species are fastidious and slow growing but can be cultured.
The Borrelia consists of three groups of species, those of the Lyme borreliosis (LB) group, also known as B. burgdorferi sensu lato (s.l.) and recently reclassified into Borreliella, the relapsing fever (RF) group Borrelia, and a third reptile-associated group of spirochetes. Culture-based methods remain the gold standard for the laboratory detection of bacterial infections for both research and clinical work, as the culture of pathogens from bodily fluids or tissues directly detects replicating pathogens and provides source material for research. Borrelia and Borreliella spirochetes are fastidious and slow growing, and thus are not commonly cultured for clinical purposes; however, culture is necessary for research. This protocol demonstrates the methodology and recipes required to successfully culture LB and RF spirochetes, including all recognized species from B. burgdorferi s.l. complex including B. afzelii, B. americana, B. andersonii, B. bavariensis, B. bissettii/bissettiae, B. burgdorferi sensu stricto (s.s.), B. californiensis, B. carolinensis, B. chilensis, B. finlandensis, B. garinii, B. japonica, B. kurtenbachii, B. lanei, B. lusitaniae, B. maritima, B. mayonii, B. spielmanii, B. tanukii, B. turdi, B. sinica, B. valaisiana, B. yangtzensis, and RFspirochetes, B. anserina, B. coriaceae, B. crocidurae, B. duttonii, B. hermsii, B. hispanica, B. persica, B. recurrentis, and B. miyamotoi. The basic medium for growing LB and RF spirochetes is the Barbour-Stoenner-Kelly (BSK-II or BSK-H) medium, which reliably supports the growth of spirochetes in established cultures. To be able to grow newly isolated Borrelia isolates from tick- or host-derived samples where the initial spirochete number is low in the inoculum, modified Kelly-Pettenkofer (MKP) medium is preferred. This medium also supports the growth of B. miyamotoi. The success of the cultivation of RF spirochetes also depends critically on the quality of ingredients.
Borrelia is a genus of spirochete bacteria that encompasses three major clades: the Lyme borreliosis (LB) group, the relapsing fever (RF) group, and a less well-characterized group seemingly restricted to reptiles. Borrelia taxonomy is in flux with the advent of molecular methodologies that allow genome and proteome comparisons, as is true of most other taxonomic groups1,2,3,4,5,6,7. The LB group (also called the Lyme disease group) has traditionally been termed Borrelia burgdorferi sensu lato after its best-characterized member Borrelia burgdorferi sensu stricto. This paper uses the currently most widely used terminology: the LB, the RF, and the reptile-associated group, and describes the culture protocols for the LB and the RF groups.
As would be expected for a member of the family Spirochaetaceae, Borrelia can adopt the distinctively long and thin spiral shape, typically 20-30 µm long and 0.2-0.3 µm wide. However, Borrelia cells are highly pleomorphic and can adopt many other shapes in both culture and in vivo1,8 as a result of their complex cellular and genetic structure. In its spirochetal form, the planar sine wave morphology results from its axial endoflagella rotating in the periplasmic space between the inner and outer membranes. This structure enables the cells to be highly motile, with the outer membrane containing proteins that enable the cell to interact with host tissues9,10. The expression of the outer membrane proteins is tightly regulated and affect not only host tissue invasion but also interaction with the host immune system11. This complex gene expression allows the Borrelia cells to shuttle between the very different environments of vertebrate hosts and invertebrate vectors. The genome of Borrelia is unusual among prokaryotes, consisting of a linear rather than a circular chromosome. In addition to the linear chromosome, Borrelia species contain 7-21 plasmids, some linear and some circular. The plasmids harbor the majority of genes required for host adaptation and virulence, and the circular plasmids derived from prophages are thought to be responsible for the majority of horizontal gene flow between spirochetal cells12,13. Consistent with a role in host adaptation, some, possibly many or all, members of the Lyme borreliosis group lose plasmids in culture14. The best studied "lab adapted" strain of B. burgdorferi, B31, has only seven of the nine plasmids found in wild isolates of this species15. Similarly, B. garinii loses plasmids in culture16. Some studies have shown that RF species and B. miyamotoi retain plasmids when cultured14,17, but recent work demonstrates altered plasmids and infectivity with long-term in vitro cultivation18.
Culture-based methods remain the gold standard for the laboratory detection of bacterial infections, for both research and clinical work14,17. The culture of pathogens from bodily fluids or tissues directly detects replicating pathogens and provides source material for research14,17. This protocol demonstrates the methodology and recipes required to successfully culture the spirochetes of the LB group as well as RF Borrelia and B. miyamotoi. The basic medium for growing Borrelia spirochetes is the Barbour-Stoenner-Kelly medium (BSK-II or the commercially available BSK-H), with or without antibiotics to reduce the growth of contaminating prokaryotes. This medium was adapted from a medium originally used to support RF Borrelia19, further modified by Stoenner20 and then by Barbour21. Many modifications have since been developed, each having effects on bacterial physiology that can affect growth, infectivity, and pathogenicity22. This medium reliably supports the growth of spirochetes in established cultures and has been used to isolate spirochetes from tick, mammal, and clinical samples23. The more recently developed variation, modified Kelly-Pettenkofer (MKP) medium, can provide better isolation success, morphology, and motility when isolating new Borrelia isolates from environmental samples, when the number of spirochetes present in the sample available to seed the culture is low23,24. In all cases, the success of cultivation is critically dependent on the freshly prepared medium and the use of appropriate ingredients; not all commercial ingredients produce high-quality medium. Inoculated cultures can be conveniently incubated without shaking in a conventional 32-34 °C incubator in the presence of a small amount of residual ambient oxygen. Borrelia spirochetes are anaerobes but are exposed in nature to fluctuations in oxygen and carbon dioxide concentrations and respond with changes in gene expression26,27,28,29. Thus, gene expression, growth, and other metabolic studies should control for oxygen and carbon dioxide levels with the use of an oxygen-controlled incubator or anaerobic chamber. In culture, cultures are checked weekly, or more often, for the presence of spirochetes with either darkfield microscopy or phase contrast microscopy. Culture smears can be stained with either silver stains, immunohistochemistry, or through the use of fluorescently tagged strains29,30. PCR followed by DNA sequencing is a sensitive and specific method to detect and genetically identify or confirm the Borrelia species30,31,32,33.
Many minor variations on BSK-II exist, and some are commercially available. The protocol described here in section 1 has been adapted from Barbour (1984)21. Liquid MKP medium is a more recently developed medium and is described in section 2. It is prepared according to a previously reported protocol33,34, which, similarly to BSK medium, consists of two steps: preparation of basic medium and preparation of complete medium. Borrelia culture medium can be prepared with or without antibiotics, as described in section 3; the antibiotics act to reduce contaminating bacteria introduced when inoculating with clinical or environmental samples, as described in section 4; if inoculating with pure Borrelia sp. culture, antibiotics may not be needed. Making long-term Borrelia stocks is often important, and a protocol for doing so is described in section 5. Section 6 describes using these media to isolate pure Borrelia sensu lato clones from clinical or environmental samples. There are a number of approaches possible36; below is one found to be effective. The plating medium used in this protocol is a modification of BSK-II plating medium37 and MKP medium34 (with rabbit serum increased to 10%38).
All studies involving samples obtained from human subject were approved by the Institutional Review Board of the relevant University and/or medical facility, and written informed consent was obtained from participants before the samples were collected. All studies involving samples obtained from animals were approved and conducted under the guidelines of the Institutional Animal Ethics Committee. Where relevant, approvals have been obtained for environmental sampling.
NOTE: The success of culture is critically dependent on the quality of ingredients. Commercial BSK medium is available and robustly supports the growth of lab-adapted pure B. burgdorferi and related species where high dose inoculum can be used to seed the culture. For isolates of strains from primary biological material, freshly prepared medium is preferred and often necessary.
Borrelia sp. are known or suspected pathogens, and unscreened human or animal tissues can also be a biohazard. Handling of potentially infectious material requires personal protective equipment and sterile technique for investigator safety. Additionally, the medium is so nutrient-rich that the culture is easily contaminated. Biosafety level 2 containment is generally required for this work and all work with Borrelia sp. or samples should be conducted in a biological safety cabinet.
1. Instructions for making BSK-II medium
Constituents | Amount (/L) |
BSA fraction V | 50 g |
CMRL-1066 (10x) | 100 mL |
Neopeptone | 5 g |
Hepes | 6 g |
Citric acid trisodium salt dihydrate | 0.7 g |
Glucose | 5 g |
TC Yeastolate | 2 g |
Pyruvic acid (Na salt) | 0.8 g |
N-acetyl-D-glucoseamine | 0.4 g |
Sodium bicarbonate | 2.2 g |
Water (high purity) | 900 mL |
Table 1: Composition of 1 L of BSK-II medium.
Source | Suitability |
Serva GmbH, Heidelberg, Germany | Yes |
Proliant Biologicals, Boone IA, USA | Yes |
Sigma (Millipore-Sigma & Sigma- Aldrich), St. Louis, MO, United States | No |
Table 2: Sources of BSA and suitability for BSK-II medium.
2. Instructions for making MKP
Constituents | Amount (/L) |
CMRL-1066 (10x without glutamine) | 100 mL (if liquid)/9.7 g/L if powder |
Neopeptone | 3 g |
Hepes | 6 g |
Citric acid | 0.7 g |
Glucose | 3 g |
Pyruvic acid | 0.8 g |
N-acetylglucoseamine | 0.4 g |
Sodium bicarbonate | 2 g |
Table 3: Composition of 1 L of basic MKP (Modified Kelly-Pettenkofer) medium.
Constituents | Amount (mL) |
Basic medium | 500 |
7% gelatin (in H2O) (freshly autoclaved but not hot) | 100 |
Rabbit serum | 36 |
35% BSA | 17.5 |
Table 4: Composition of MKP (Modified Kelly-Pettenkofer) complete medium.
3. Culture of Borrelia, with or without antibiotics
4. Long-term storage of Borrelia cultures
5. Isolation of spirochetes from environmental or clinical sources
NOTE: If isolating material from human, animal, or environmental sources, research ethics, animal care, or ecological certification, as appropriate, must be obtained.
6. Isolation of monoclonal populations of B. burgdorferi sensu lato spirochetes and B. miyamotoi from liquid cultures by cultivation on solid media
Borrelia culture media BSK and MKP, and variants, are rich culture media with ingredients that need to be prepared and sterilized sequentially. When correctly prepared, BSK medium should be red-orange and clear (Figure 1). Turbidity and precipitation that persist after warming indicate problematic ingredients, medium production, or contamination; such medium is best discarded. If gelatin is added to BSK and with MKP, the medium will be gelatinous when refrigerated; upon warming, it will be liquid, although slightly viscous.
The growth of pure Borrelia cultures will not change the turbidity of the medium. However, the growth of bacterial cultures, Borrelia, as well as contaminants, will change medium color as a result of the pH indicator. Overgrowth by other bacteria will produce turbidity and clumped materials (Figure 2).
Culture growth can be monitored by phase contrast or darkfield microscopy (Figure 3 and Figure 4). Borrelia cells in the exponential phase are typically slender and kinked, and motile to some extent. As the cultures go into the stationary phase, round bodies are increasingly evident (Figure 5). Clinical or environmental isolates frequently contain multiple Borrelia strains and/or species. To isolate pure clones, liquid cultures can be plated to isolate monoclonal colonies (Figure 6); sometimes, multiple rounds of colony isolation may be needed.
Figure 1: BSK and MKP medium. (A) BSK (with antibiotics) with a pure culture of Borrelia burgdorferi. With or without B. burgdorferi medium remains without visible turbidity and is orange-amber (color varies slightly with ingredients). (B) MKP medium, uninoculated, thawing. Please click here to view a larger version of this figure.
Figure 2: Contaminated BSK and MKP medium with overgrowth of competing bacteria. Medium is discolored, turbid, and over time competing bacteria die and precipitate to the bottom of the tube. (A) Overgrown BSK tube. (B) Old BSK tube with precipitated contaminating bacteria. (C) MKP tube with (left) and without (middle) culture and contaminated culture (right). Please click here to view a larger version of this figure.
Figure 3: Use of a hemocytometer to monitor Borrelia growth. Borrelia burgdorferi strain B31 (a subset indicated by arrows) viewed on a hemocytometer (one line of the small grid is indicated by the arrowhead) under 200X phase contrast. This magnification and process allow monitoring of cultures and estimation of cell density. Scale bar is 10 µm. Please click here to view a larger version of this figure.
Figure 4: Darkfield image of Borrelia burgdorferi. Darkfield image of Borrelia burgdorferi strain SCW-53, at high density in exponential phase after 5-7 days of cultivation in MKP medium (400X magnification). Scale bar is 20 µm. This strain was isolated from the hard tick Ixodes affinis, collected in South Carolina, USA. Please click here to view a larger version of this figure.
Figure 5: Borrelia in old cultures. As Borrelia cells go into the stationary phase in old cultures, round body forms are increasingly seen to replace the spirochetal form. These may be dormant forms or dead cells. Left panel, Dieterle stain; middle panel, immunohistochemistry stain; and right panel, fluorescent in situ hybridization of a Borrelia culture (presumed to be B. burgdorferi based on origin but the species and strain was not molecularly identified) inoculated with canine urine. Collection of the data in Figure 5 was approved by the Mrt. Allison University Animal Care Committee, approval number 16-1. Please click here to view a larger version of this figure.
Figure 6: Borrelia burgdorferi sensu lato complex spirochetes. Colonies of Borrelia burgdorferi sensu lato complex spirochetes grown on solid medium in order to isolate pure clonal populations. Please click here to view a larger version of this figure.
The laboratory culture of bacteria is the springboard for research. The profound advantage conferred by the ability to culture is exemplified by the struggle, over more than a century culminating only recently in success, to culture Treponema pallidum, the spirochete that is the etiological agent of syphilis44. Borrelia spirochetes are also challenging to culture, but culture is possible23,24,34,44,45,46,47,48,49.
Borrelia cells are fastidious and each species and strain, and even isolate differs, both genetically and through adaptation to the host from which they have been isolated51,52,53,54,55. When making media, the use of appropriate ingredients make an enormous difference in the vigor of Borrelia culture or even the viability of the culture. The use of freshly prepared, highly enriched, and properly stored medium is essential to promote bacterial growth and is a well-established requirement for bacterial growth. For Borrelia, maintaining anaerobic or microaerobic conditions is required for good growth. This can be achieved most simply by filling tubes to the top, so there is little to no air remaining in the tube and growing the cultures without agitation; more stringent control of oxygen and carbon dioxide may be required for gene expression and related studies26,27,28,29,30. The addition of antibiotics to the bacterial culture medium may seem counter-intuitive; the use of low doses of antibiotics in the Borrelia medium is to discourage the growth of faster-growing bacteria. If the culture is inoculated with a pure Borrelia isolate, the addition of antibiotics is not needed; however the use of added antibiotics is essential to discourage overgrowth from competing bacteria when inoculating with clinical or environmental samples. BSK medium can also be supplemented with 3%-7% gelatin. This is needed for the growth of RF Borrelia species21. The use of BSK or MKP for the growth of Borrelia burgdorferi sensu lato species depends on the source of the isolate. Both media support the growth of established cultures, but MKP has been found to perform better when seeding new cultures with low numbers of Borrelia cells, such as occurs with clinical or environmental isolates23,24. This medium also allows the culture of B. miyamotoi56,57,58. Ultimately, there is an element of art to the science of growing fastidious microbes, but it is possible with care and persistence.
The culture of Borrelia underlies advances in biomedical research. The culture of Borrelia has allowed determination of the full genome and proteome of many Borrelia species, which has permitted researchers to start to unravel the evolution and biology of these spirochetes54,58,59. Similarly, access to pure cultures of Borrelia allows the understanding of the many complex interactions of Borrelia with the mammalian host and arthropod vector61,62,63,64,65, including interactions with the host immune system11,65, allows mechanisms of transmission to be inferred29,66, and provides the key investigative tool to distinguish culturable, hence necessarily living, cells from cellular debris, a distinction that is critical in unraveling the mechanisms of pathogenesis as well as effective treatment regimens8,67,68,69,70,71. While the in vitro Borrelia culture can take several weeks before spirochetes are sufficiently abundant for detection, limiting clinical diagnostic applications, fundamental understanding of Borrelia biology, genomics, host-pathogen interactions, and many more applications has relied on the ability to isolate pure Borrelia cultures from environmental isolates, and to amplify those isolates through culture to produce sufficient material for biochemical and genetic analysis. There is a societal push for rapid response to infections to support rapid diagnosis and treatment. The other component of this need, however, is the biomedical and biological research needed for a solid foundation upon which to appropriately and successfully treat and prevent disease. While challenging, in vitro cultivation of Borrelia spirochetes is possible and can support these needs.
The authors have nothing to disclose.
This work was partially supported by the Natural Science and Engineering Research Council of Canada and the Canadian Lyme disease Foundation (AB and VL), the Swedish Research Council (SB, M-LF and IN), TAČR GAMA 2 project – "Support of application potential verification 2.0 at the Biology Centre CAS" (TP01010022) (MG and NR), and by a grant from Ministry of Health of the Czech Republic NV19-05-00191 (MG and NR). We thank S. Vranjes (2021, Rudenko lab) for the image in Figure 4 and J. Thomas-Ebbett (2021, Lloyd lab) for the images in Figure 5. We thank all researchers who have contributed to the field and apologize to those whose work we were not able to cite due to space limitations.
1.7 mL tubes | VWR | 87003-294 | Standard item – any supplier will do |
0.2 µm Sterile syringe filter | VWR | 28145-501 | Standard item – any supplier will do |
10 µL barrier pipette tip | Neptune | BT10XLS3 | Standard item – any supplier will do |
10 mL Serological pipettes | Celltreat | 229011B | Standard item – any supplier will do |
1000 µL barrier pipette tip | Neptune | BT1000.96 | Standard item – any supplier will do |
15 mL tube | Celltreat | 188261 | Standard item – any supplier will do |
20 µL barrier pipette tip | Neptune | BT20 | Standard item – any supplier will do |
20 mL Sterile syringe | BD | 309661 | Standard item – any supplier will do |
200 µL barrier pipette tip | Neptune | BT200 | Standard item – any supplier will do |
25 mL Screw Cap Culture Tubes | Fisher Scientific | 14-933C | Standard item – any supplier will do |
25 mL Serological pipettes | Celltreat | 229025B | Standard item – any supplier will do |
3 mL Sterile syringe | BD | 309657 | Standard item – any supplier will do |
35% BSA | Sigma | A-7409 | Source is important – see note |
5 mL Serological pipettes | Celltreat | 229006B | Standard item – any supplier will do |
50 mL tube | Celltreat | 229421 | Standard item – any supplier will do |
6.5 ml MKP glass tubes | Schott | Schott Nr. 26 135 115 | Standard item – any supplier will do |
Amikacine | Sigma | PHR1654 | Standard item – any supplier will do |
Amphotericin B | Sigma | A9528-100MG | Standard item – any supplier will do |
Bactrim/rimethoprim/sulfamethoxazole | Sigma | PHR1126-1G | Standard item – any supplier will do |
BBL Brucella broth | BD | 211088 | Standard item – any supplier will do |
Biosafety Cabinet | Labconco | 302419100 | Standard item – any supplier will do |
Blood collection tubes (yellow top – ACD) | Fisher Scientific | BD Vacutainer Glass Blood Collection Tubes with Acid Citrate Dextrose (ACD) | Standard item – any supplier will do |
BSK-H Medium [w 6% Rabbit serum] | Darlynn biologicals | BB83-500 | Standard item – any supplier will do |
centrifuge | Eppendorf | model 5430 | Standard item – any supplier will do |
Citric acid TrisodiumSaltDihydrate | Sigma | C-8532 100 g | Standard item – any supplier will do |
CMRL | Gibco BRL | 21540 500 mL | Standard item – any supplier will do |
CMRL-1066 | Gibco | 21-510-018 | Standard item – any supplier will do |
Cryogenic Tubes (Nalgene) | Fisher Scientific | 5000-0020 | Standard item – any supplier will do |
Deep Petri with stacking ring 100 mm × 25 mm | Sigma | P7741 | Standard item – any supplier will do |
Digital Incubator | VWR | model 1545 | Standard item – any supplier will do |
DMSO | ThermoFisher | D12345 | Standard item – any supplier will do |
Filters for filter sterilization | Millipore 0.22μm GPExpressPLUS Membrane | SCGPU05RE | Standard item – any supplier will do |
Gelatin | Difco BD | 214340 500 g | Standard item – any supplier will do |
Glass Culture Tubes | Fisher Scientific | 99449-20 | Standard item – any supplier will do |
Glucose | Sigma | G-7021 1 kg | Standard item – any supplier will do |
Glycerol | Sigma | G5516 | Standard item – any supplier will do |
Hemafuge (Hematocrit & Immuno hematology centrifuge ) | Labwissen | Model 3220 | Standard item – any supplier will do |
HEPES | Sigma | H-3784 100 g | Standard item – any supplier will do |
N-acetylglucoseamine | Sigma | A-3286 25 g | Standard item – any supplier will do |
Neopeptone | Difco BD | 211681 500 g | Standard item – any supplier will do |
Neubauer Hematocytometer | Sigma | Z359629 | Standard item – any supplier will do |
Phase contrast microscope | Leitz | Standard item – any supplier will do | |
Phosphomycin | Sigma | P5396-1G | Standard item – any supplier will do |
Phosphomycine | Sigma | P5396 | Standard item – any supplier will do |
Pipetboy | Integra | Standard item – any supplier will do | |
Precision Standard Balance | OHAUS | model TS200S | Standard item – any supplier will do |
Pyruvic acid (Na salt) | Sigma | P-8574 25 g | Standard item – any supplier will do |
Rabbit Serum | Gibco | 16-120-032 | Source is important |
Rabbit Serum | Sigma | R-4505 100 mL | Source is important |
Rifampicin | Sigma | R3501-1G | Standard item – any supplier will do |
Sodium bicarbonate | Sigma | S-5761 500 g | Standard item – any supplier will do |
Sufametaxazole | Sigma | PHR1126 | Standard item – any supplier will do |
TC Yeastolate | Difco BD | 255752 100 g | Standard item – any supplier will do |
Transfer Pipettes | VWR | 470225-044 | Standard item – any supplier will do |
Trimethoprim | Sigma | PHR1056 | Standard item – any supplier will do |